BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Baxter
Harvard Business School
Argus Health
US Army
Merck
Chinese Patent Office
Fuji
Citi
Farmers Insurance

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,785,053

« Back to Dashboard

Summary for Patent: 5,785,053
Title: Inserter for the positioning of an intrauterine device
Abstract:An inserter for the positioning of an intrauterine device in the uterus, which inserter includes a plunger, a handle attached to the plunger, a string for the removal of the IUD, a locking device to lock the string in such a way that the IUD remains immobile in relation to the plunger, and a protective tube around the plunger. The protective tube is arranged in relation to the plunger in such a way that it can be pushed, at the forward end that goes into the uterus, past the plunger at distance (L) , which corresponds substantially to the length of the IUD assembled for insertion. The stop members ensure that the front edge of the protective tube is stopped in a configuration in which the hemispherical tips of the wings of the transverse member of a T-shaped IUD remain partly uncovered by the protective tube, but the wings nevertheless remain pressed against each other.
Inventor(s): Macandrew; John (St. Neots, GB3), Conway; John (Sawston, GB3), Paton; Michael (Royston, GB3), Gardner; Richard (Royston, GB3), Rauramo; Ilkka (Espoo, FI), Lehtinen; Matti (Piispanristi, FI)
Assignee: Leiras Oy (Turku, FI)
Application Number:08/849,550
Patent Claim Types:
see list of patent claims
Device; Use;

Drugs Protected by US Patent 5,785,053

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,785,053

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Finland945895Dec 15, 1994
PCT Information
PCT FiledDecember 05, 1995PCT Application Number:PCT/FI95/00666
PCT Publication Date:June 20, 1996PCT Publication Number: WO96/18365

International Patents Family Members for US Patent 5,785,053

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 235201 ➤ Subscribe
Australia 4118096 ➤ Subscribe
Australia 693297 ➤ Subscribe
Bulgaria 101744 ➤ Subscribe
Bulgaria 62472 ➤ Subscribe
Brazil 9510078 ➤ Subscribe
Canada 2204368 ➤ Subscribe
China 1147277 ➤ Subscribe
China 1168626 ➤ Subscribe
Czech Republic 286820 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Fuji
Chubb
Cipla
Federal Trade Commission
Harvard Business School
Queensland Health
Healthtrust
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot